IDEXX Laboratories Inc (IDXX : NASDAQ)
Common Stock
$671.64
USD
+120.43 (21.85%)
Last updated: 2026-11-02
Follow IDXX
IDXX
IDEXX Laboratories Inc
WealthAwesomePerformance
1 Day
+21.85%
1 Week
+17.79%
1 Month
+29.56%
YTD
+0.25%
Key Statistics
Market Cap
$52.91B
52W High
$769.98
52W Low
$500.61
P/E Ratio
38.73
50 Day MA
$534.27
200 Day MA
$572.62
Beta
1.54
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/2/2026 | $625.00 | $673.19 | $620.20 | $671.64 | $671.64 | 1,947,551 |
| 10/30/2026 | $583.75 | $586.00 | $540.61 | $551.21 | $551.21 | 1,173,500 |
| 10/29/2026 | $570.17 | $576.17 | $568.01 | $575.98 | $575.98 | 476,407 |
| 10/28/2026 | $556.78 | $567.77 | $555.21 | $562.91 | $562.91 | 351,839 |
| 10/27/2026 | $563.23 | $567.54 | $559.03 | $561.25 | $561.25 | 488,028 |
| 10/26/2026 | $564.23 | $571.75 | $557.94 | $570.21 | $570.21 | 528,140 |
| 10/23/2026 | $564.80 | $569.56 | $558.29 | $560.38 | $560.38 | 398,300 |
| 10/22/2026 | $562.01 | $568.67 | $558.39 | $566.76 | $566.76 | 430,082 |
| 10/21/2026 | $549.70 | $560.63 | $547.48 | $553.48 | $553.48 | 404,571 |
| 10/20/2026 | $559.14 | $561.83 | $552.78 | $557.93 | $557.93 | 439,477 |
Analyst Price Targets
Based on 14 analysts covering IDXX · as of Nov 3, 2026
Wall Street analysts forecast IDXX stock price to rise 3.5% over the next 12 months.
Consensus
Buy3.93 / 5.00
Avg. Target
US$694.83
+3.5% Upside
Previously US$694.42 on Oct 29, 2026
Current Price
US$671.64
Last close
Analyst Breakdown (14 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on IDXX's historical volatility
30-Day Vol
62.9%
Annualized
90-Day Vol
43.8%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
US$802.95
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$712.83 | US$573.75 – US$885.63 |
| 60 trading days | US$756.55 | US$556.58 – US$1028.37 |
| 90 trading days | US$802.95 | US$551.34 – US$1169.39 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About IDEXX Laboratories Inc
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Financials
- Revenue (TTM)
- $4.55B
- EBITDA
- $1.62B
- Profit Margin
- 25.03%
- ROE (TTM)
- 74.21%
- EPS (Diluted)
- 17.34
- Book Value
- 20.14
Classification
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Group
- Health Care Equipment & Services
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About IDXX.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| VCIG | VCI Global Limited Ordinary Share | $8.16 | +4728.40% |
| RETO | ReTo Eco-Solutions Inc | $4.16 | +647.26% |
| BJDX | Bluejay Diagnostics Inc | $2.12 | +281.02% |
| INO | Inovio Pharmaceuticals Inc | $1.89 | +215.00% |
| CLRO | ClearOne Inc | $5.65 | +65.69% |
| INLF | INLIF LIMITED Ordinary Shares | $0.29 | +56.76% |
| AMPGZ | Amplitech Group, Inc. Series B Right | $0.06 | +55.50% |
| GENVR | Gen Digital Inc. Contingent Value Rights | $2.85 | +52.41% |
IDXX.US news timeline
12 articles covering IDXX.US, most recent first
Latest